The findings confirm and expand the results reported previously[21], in which we found that ASIV protects against Iso-induced cardiac hypertrophy in terms of ratios of HW/BW and LHW/BW as well as ANP and BNP mRNA expression. The gene discussed is NPPA; the disease is cardiac hypertrophy.